Design of novel therapeutics targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) to aid weight loss-Reference-Cited by-同舟云学术

Design of novel therapeutics targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) to aid weight loss

Published:2023-05-08 Issue:6 Volume:18 Page:659-669
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Davies Iona¹,Tan Tricia M.M¹

Affiliation:

1. Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK

Funder

Medical Research Council

National Institute for Health and Care Research

National Institute for Health and Care Research Biomedical Research Centre

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2023.2203911

Reference83 articles.

1. Health survey for England, 2021: data tables. NHS Digital, 2022. Available at: https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2021/health-survey-for-england-2021-data-tables [cited 17 Jan 2023].

2. Share of adults that are obese, 2016. OurWorldInData.org/obesity. Oxford (UK), 2016. Available at: https://ourworldindata.org/grapher/share-of-adults-defined-as-obese [cited 17 Jan 2023].

3. Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

4. Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters

5. Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucagon-based therapy for people with diabetes and obesity: What is the sweet spot?;Peptides;2024-06

2. Incretin and glucagon receptor polypharmacology in chronic kidney disease;American Journal of Physiology-Endocrinology and Metabolism;2024-06-01

3. Targeting the incretin system in obesity and type 2 diabetes mellitus;Nature Reviews Endocrinology;2024-04-17